Group 1 - The sixth batch of national high-value medical consumables procurement results has been released, with 202 companies and 440 products successfully selected, focusing on price reduction through "volume for price" strategy [1] - The introduction of "anchor pricing" aims to ensure that price reductions do not compromise quality, with a mechanism that calculates an average price and sets a reference point for bidding [1][2] - The "anchor price" is set at 65% of the average bid, which serves as a benchmark for companies to ensure their bids remain competitive yet sustainable [1][2] Group 2 - The "revival mechanism" allows companies that did not win in the first round to submit new bids, providing a second chance for quality products that may have been priced too high [2] - This dual mechanism of "anchor pricing" and "revival mechanism" is designed to filter out reasonably priced and reliable quality products, preventing unsustainable low bidding [2] - The overall outcome of these mechanisms is expected to stabilize prices and quality, ultimately benefiting patients by providing more choices in medical consumables [3]
医用耗材集采启用新机制 一“防”一“保”为患者选出放心好产品
Yang Shi Xin Wen·2026-01-16 06:51